助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   非胰腺癌 的翻译结果: 查询用时:0.022秒
图标索引 在分类学科中查询
所有学科
更多类别查询

图标索引 历史查询
 

非胰腺癌
相关语句
  non-pancreatic cancer
     Results:The positive rate of plasma K-ras mutation in patients with pancreatic carcinoma was dramatically higher than that in non-pancreatic cancer patients(73% vs 15%,χ 2=49.0,P<0.001).
     结果 :胰腺癌组患者血浆K ras基因突变阳性率为 73% (6 6 / 90 ) ,显著高于非胰腺癌组 15 % (9/ 6 0 ) (χ2 =4 9.0 ,P <0 .0 0 1)。
短句来源
     Methods:150 hospitalized patients consisted of 90 pancreatic cancer patients and 60 non-pancreatic cancer patients were obsered in present study.
     方法 :胰腺癌病人 90例 ,非胰腺癌组 6 0例。
短句来源
  “非胰腺癌”译为未确定词的双语例句
     \ Results\ The positive rate of TGFβRⅡ in pancreatic carcinoma was 96%(48/50) and in pancreatic nonneoplastic tissue was 100%(38/38).
     结果TGF-βRⅡ在胰腺癌组织中表达阳性率为96%(48/50),在非胰腺癌组织中表达阳性率为100%(38/38)。
短句来源
     \ But the rate of TGFβRⅡ expression with moderate intensity or more(~) in pancreatic carcinoma(70%,35/50) was lower than in pancreatic nonneoplastic tissue(100%,38/38)(P<0.01).
     两者在统计学上差别无意义,但在表达的强度上存在差异。 TGF-βRⅡ在胰腺癌组织中等强度以上表达率为70%(35/50),明显低于非胰腺癌组织100%(38/38)(P<0.01)。
短句来源
     Methods CED-RFLP/PCR technique was used to detect K-ras gene mutation in the plasma specimens of pancreatic cancer patients, patients with benign pancreatic diseases and healthy subjects.
     方法以血浆代替以往的标本并采用CED-RFLP/PCR技术检测胰腺癌、非胰腺癌患者及健康对照者血浆K-ras基因突变情况。
短句来源
     We selected some none-PC cases as control group when we quantified and scored a certain symptom.
     在进行某些症状量化评分时,选取了部分非胰腺癌对照组。
短句来源
     Pathologic results confirmed pancreatic cancer in 33 cases and not confirmed pancreatic cancer in 9 cases.
     病理结果 :胰腺癌 3 3例 ,非胰腺癌 9例。
短句来源
更多       
  相似匹配句对
     PANCREATIC SCHISTOSOMIASIS
     血吸虫病
短句来源
     Pancreatic Cancer
    
短句来源
     Spiral CT features of nonfunctioning endocrine tumors of the pancreas
     功能性内分泌肿瘤的螺旋CT表现
短句来源
     THE MANAGEMENT OF POSTOPERATIVE PANCREATIC FISTULAS BY ENDOSCOPIC NASOPANCREATIC DUCT DRAINAGE
     胆术后瘘的手术引流
短句来源
     Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats
     大鼠腺癌腺组织的KiSS-1 mRNA表达
短句来源
查询“非胰腺癌”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


Objective\ To study the expression of the type Ⅱ transforming growth factorbeta receptor(TGFβRⅡ) in pancreatic carcinoma and its significance.\ Methods\ By using immunohistochemical methods,expression of TGFβRⅡ was studied in 50 cases of pancreatic carcinoma,38 cases of pancreatic nonneoplastic tissue(benign pancreatic diseases and normal pancreatic tissue).\ Results\ The positive rate of TGFβRⅡ in pancreatic carcinoma was 96%(48/50) and in pancreatic nonneoplastic...

Objective\ To study the expression of the type Ⅱ transforming growth factorbeta receptor(TGFβRⅡ) in pancreatic carcinoma and its significance.\ Methods\ By using immunohistochemical methods,expression of TGFβRⅡ was studied in 50 cases of pancreatic carcinoma,38 cases of pancreatic nonneoplastic tissue(benign pancreatic diseases and normal pancreatic tissue).\ Results\ The positive rate of TGFβRⅡ in pancreatic carcinoma was 96%(48/50) and in pancreatic nonneoplastic tissue was 100%(38/38).\ But the rate of TGFβRⅡ expression with moderate intensity or more(~) in pancreatic carcinoma(70%,35/50) was lower than in pancreatic nonneoplastic tissue(100%,38/38)(P<0.01).\ The expression intensity of TGFβRⅡ in pancreatic carcinoma decreased with decreasing grades of differentiation (P<0.01).\ Conclusion\ Loss of TGFβRⅡ expression may be involved in pancreatic carcinoma.\ The expression intensity of TGFβRⅡ was closely correlated to differentiation of pancreatic carcinoma.

目的研究转化生长因子βⅡ型受体(TGF-βRⅡ)在胰腺癌组织中的表达情况,探讨其临床病理意义。方法应用免疫组化SP法结合微波抗原修复法检测50例胰腺癌和38例非胰癌组织(胰腺良性病变及正常组织)中TGF-βRⅡ表达情况。结果TGF-βRⅡ在胰腺癌组织中表达阳性率为96%(48/50),在非胰腺癌组织中表达阳性率为100%(38/38)。两者在统计学上差别无意义,但在表达的强度上存在差异。TGF-βRⅡ在胰腺癌组织中等强度以上表达率为70%(35/50),明显低于非胰腺癌组织100%(38/38)(P<0.01)。TGF-βRⅡ在胰腺癌中的表达强度随着组织分化程度的降低而降低(P<0.01)。结论TGF-βRⅡ低表达可能与胰腺癌的发生有关。TGF-βRⅡ的表达强度与胰腺癌的组织分化密切相关。

Objective To evaluate dual phase spiral CT scanning in assessing the resectability of pancreatic cancer.Materials and Methods The resectability and diagnosis were prospectively evaluated in 42 patients with suspicious pancreatic cancer who underwent surgery later. Pathologic results confirmed pancreatic cancer in 33 cases and not confirmed pancreatic cancer in 9 cases. Dual phase CT scans were obtained with the delayed time of 25 or 60 seconds, respectively. A comparison of CT diagnosis with surgical findings...

Objective To evaluate dual phase spiral CT scanning in assessing the resectability of pancreatic cancer.Materials and Methods The resectability and diagnosis were prospectively evaluated in 42 patients with suspicious pancreatic cancer who underwent surgery later. Pathologic results confirmed pancreatic cancer in 33 cases and not confirmed pancreatic cancer in 9 cases. Dual phase CT scans were obtained with the delayed time of 25 or 60 seconds, respectively. A comparison of CT diagnosis with surgical findings was made.Results Of total 42 cases, 39 (93%) were correctly diagnosed on spiral CT. For prediction of resectability, spiral CT carries an accuracy of 91%, sensitivity of 89% and specificity of 92%. CT detected liver metastases in 8 of 10 cases (80%) and peritoneal carcinomatosis in 5 of 9 cases (56%), and correct judgement as whether the peripancreatic vessels were invaded was obtained in 19 of 21 cases (91%).Conclusion (1) Spiral CT scanning exhibits high accuracy both in diagnosing pancreatic cancer and in assessing the peripancreatic vascular invasion, therefore, it is the most valuable and precise imaging technique for preoperative assessment of pancreatic cancer. (2) Dual phase thin slice spiral CT scanning can accurately assess the peripancreatic vessels, though it has limited value in detecting small liver metastases and peritoneal carcinomatosis.

目的 评价螺旋CT双期扫描对胰腺癌可切除性的价值。材料与方法 对 42例拟诊胰腺癌随后又行手术治疗的患者作出前瞻性的诊断和可切除性的评估。病理结果 :胰腺癌 3 3例 ,非胰腺癌 9例。CT双期延迟扫描时间分别为 2 5s和 60s。并将CT判断的结果与手术结果作对比。结果  42例中 ,螺旋CT正确诊断 3 9例 ( 93 % )。螺旋CT判断可切除性的敏感性为 89% ,特异性为92 % ,准确性为 91%。 10例肝转移癌 ,CT诊断 8例 ( 80 % ) ;9例腹膜癌变 ,CT诊断 5例 ( 5 6% ) ;关于胰周血管是否受侵 ,2 1例中CT判断正确 19例 ( 91% )。结论 螺旋CT不仅诊断胰腺癌的准确性高 ,而且判断其可切除性的准确性也高 ,因而是诊断和术前评估胰腺癌最全面而准确的影像学手段之一。螺旋CT双期薄层扫描判断胰周血管是否受侵的准确性较高 ,从而提高了可切除性判断的准确性 ,但对肝内小转移灶和腹膜癌变的诊断存在局限性

Objective To evaluate neurolytic celiac plexus block (NCPB) under CT guidance in controlling upper abdominal cancer pain, and to discuss the technical points of NCPB.Materials and Methods Bilateral NCPB with ethanol under CT guidance via posterior approach was performed in 58 patients with intractable upper abdominal pain or referred back pain caused by cancer of pancreas, liver, stomach, colon or bile duct. The analgesic effect was classified into 0~Ⅲ grade. Patients were divided into two groups: pancreatic...

Objective To evaluate neurolytic celiac plexus block (NCPB) under CT guidance in controlling upper abdominal cancer pain, and to discuss the technical points of NCPB.Materials and Methods Bilateral NCPB with ethanol under CT guidance via posterior approach was performed in 58 patients with intractable upper abdominal pain or referred back pain caused by cancer of pancreas, liver, stomach, colon or bile duct. The analgesic effect was classified into 0~Ⅲ grade. Patients were divided into two groups: pancreatic cancer group and non pancreatic cancer group. The therapeutic effect of two groups was compared. The spreading of neurolytic solution, which was added with contrast material, was observed by using 3 D reconstruction on a work station.Results The effective rates for pain relief in 2 weeks, 1,2 and 3 months were 93.10%, 87.93%, 85.45% and 79.59%, respectively. No significant difference was found between pancreatic cancer group and non pancreatic cancer group. In patients with ideal results good diffusion of the contrast surrounding the aorta could be seen. No severe complications occurred in this study.Conclusion Bilateral ethanol NCPB via posterior approach guided with CT is an effective and safe technique for controlling intractable upper abdominal cancer pain.

目的 评价CT导引下腹腔神经丛阻滞治疗上腹部癌性疼痛的应用价值 ,并对其技术方法等进行探讨。材料与方法  5 8例由胰腺癌、肝癌、胃癌、结肠癌、胆管癌引起的顽固性上腹痛或伴有牵涉性背痛的患者经CT导引后路双侧腹腔神经丛酒精阻滞 ,止痛效果被分为 0~Ⅲ级。将 5 8例分为胰腺癌组及非胰腺癌组 ,并将两组疗效进行对比。利用工作站三维重建观察对比剂扩散情况。结果 经 3个月随访 ,2周、1个月、2个月、3个月止痛总有效率分别为 93 .10 %、87.93 %、85 .45 %和 79.5 9%。胰腺癌组和非胰腺癌组对比 ,止痛总有效率无显著差异。止痛效果良好的患者可观察到对比剂扩散较好 ,能从两侧相互汇合包绕腹主动脉。 5 8例中无 1例出现严重并发症。结论 CT导引下双侧后路腹腔神经丛阻滞是治疗上腹顽固性癌性疼痛的有效、安全的方法

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关非胰腺癌的内容
在知识搜索中查有关非胰腺癌的内容
在数字搜索中查有关非胰腺癌的内容
在概念知识元中查有关非胰腺癌的内容
在学术趋势中查有关非胰腺癌的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社